2+ hour, 10+ min ago  (147+ words) The details for the poster presentation, which will be presented by Tyrell Simkins, D. O. , Ph. D. , Senior Director, Clinical Development, are below: Poster Title: ALSTARS: A Precision Immunomodulatory Phase 2 Trial Of Coya 302 Targeting Regulatory T Cells And Neuroinflammation In ALS Authors: Tyrell…...

17+ min ago  (594+ words) Bio Space i Qure Pharma Awarded Grant from The Michael J. Fox Foundation to Advance EAAT2 Program in Parkinson's Disease PRINCETON, N. J. , June 18, 2026 /PRNewswire/ -- i Qure Pharma, a clinical-stage biotech company developing first-in-class astrocyte-targeted therapies designed to restore glutamate balance in CNS disorders,…...

20+ min ago  (399+ words) ATLANTA, June 18, 2026 /PRNewswire/ -- Nyra Medical, a leading innovator in structural heart therapies, today announced that it has been selected as the recipient of the 2026 Jon De Haan Foundation Award for Cardiovascular Innovation, presented during Euro PCR 2026, the world's leading course…...

24+ min ago  (355+ words) Bio Space Med Tech Innovator Welcomes Dr. Jeffrey Shuren as Advisor World's largest medtech accelerator strengthens regulatory leadership to support best-in-class medical technology startups LOS ANGELES--(BUSINESS WIRE)--#Innovation--Med Tech Innovator (MTI), the world's largest accelerator of medical technology…...

6+ hour, 7+ min ago  (83+ words) Growing body of evidence supports Allo Sure" as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomes Key Study Findings in Kidney Transplantation: Key Study Findings in Heart Transplantation: New Study Finding in Multiorgan Transplantation: A panel…...

55+ min ago  (594+ words) Bio Space ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual function testing while…...

56+ min ago  (353+ words) Company is advancing its proprietary LYNX" drug delivery platform to develop oral therapies that last for up to a month, including a monthly oral contraceptive "The LYNX platform attracted us with its potential to address significant unmet medical needs," said…...

1+ hour, 7+ min ago  (191+ words) Prospective, multicenter study is the first to systematically evaluate staged, bilateral MRg FUS in Parkinson's disease, showing 66. 8% improvement in motor complications and substantial reduction in the proportion of patients experiencing dyskinesia at three months In this study, patient-reported time spent…...

1+ hour, 18+ min ago  (992+ words) Bio Space Scribe Therapeutics Awarded More Than $25 Million From CIRM to Accelerate Additional CRISPR-Based Gene Editing Therapies for Cardiometabolic Disease Into Clinical Trials - Scribe received multi-year grant awards from the California Institute for Regenerative Medicine (CIRM) to advance two therapeutic…...

1+ hour, 22+ min ago  (650+ words) Bio Space Alzheimer's Drug Discovery Foundation Begins Search for New Chief Science Officer as Co-Founder Dr. Howard Fillit Transitions to Emeritus Role Building on three decades shaping Alzheimer's science, the ADDF is poised to lead the next era of breakthroughs,…...